Guided Therapeutics - 29 Year Stock Price History | GTHP
Historical daily share price chart and data for Guided Therapeutics since 1996 adjusted for splits and dividends. The latest closing stock price for Guided Therapeutics as of May 01, 2025 is 0.10.
- The all-time high Guided Therapeutics stock closing price was 28.25 on February 04, 1997.
- The Guided Therapeutics 52-week high stock price is 0.23, which is 130% above the current share price.
- The Guided Therapeutics 52-week low stock price is 0.06, which is 40% below the current share price.
- The average Guided Therapeutics stock price for the last 52 weeks is 0.13.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| Guided Therapeutics Historical Annual Stock Price Data |
| Year |
Average Stock Price |
Year Open |
Year High |
Year Low |
Year Close |
Annual % Change |
| 2025 |
0.1124 |
0.1430 |
0.1600 |
0.0770 |
0.1050 |
-30.00% |
| 2024 |
0.1380 |
0.1450 |
0.2000 |
0.0640 |
0.1500 |
-2.60% |
| 2023 |
0.2037 |
0.3300 |
0.3600 |
0.1090 |
0.1540 |
-48.67% |
| 2022 |
0.5027 |
0.6520 |
0.7300 |
0.2290 |
0.3000 |
-48.28% |
| 2021 |
0.6240 |
0.2899 |
0.9100 |
0.2899 |
0.5800 |
93.40% |
| 2020 |
0.2981 |
0.1600 |
0.5600 |
0.1226 |
0.2999 |
125.49% |
| 2019 |
0.1423 |
0.0003 |
0.2547 |
0.0002 |
0.1330 |
44233.33% |
| 2018 |
0.0063 |
0.0253 |
0.0253 |
0.0002 |
0.0003 |
-98.80% |
| 2017 |
0.2260 |
0.5550 |
1.9200 |
0.0141 |
0.0250 |
-95.36% |
| 2016 |
0.2318 |
0.0148 |
2.4200 |
0.0006 |
0.5386 |
3490.67% |
| 2015 |
0.1127 |
0.2250 |
0.2450 |
0.0138 |
0.0150 |
-93.48% |
| 2014 |
0.4211 |
0.4790 |
0.6000 |
0.2130 |
0.2299 |
-52.10% |
| 2013 |
0.6801 |
0.6750 |
0.9400 |
0.4600 |
0.4800 |
-29.41% |
| 2012 |
0.7925 |
1.5400 |
1.7400 |
0.5190 |
0.6800 |
-55.26% |
| 2011 |
0.9743 |
0.7700 |
1.5200 |
0.6900 |
1.5200 |
90.00% |
| 2010 |
0.8692 |
1.0500 |
1.4300 |
0.6800 |
0.8000 |
-28.57% |
| 2009 |
0.5383 |
0.3300 |
1.6000 |
0.2000 |
1.1200 |
460.00% |
| 2008 |
0.2714 |
0.2000 |
0.4500 |
0.1100 |
0.2000 |
5.26% |
| 2007 |
0.4002 |
0.2500 |
0.7500 |
0.1900 |
0.1900 |
-36.67% |
| 2006 |
0.5060 |
0.2500 |
1.5000 |
0.1851 |
0.3000 |
20.00% |
| 2005 |
0.3182 |
0.6500 |
0.6500 |
0.1700 |
0.2500 |
-50.98% |
| 2004 |
1.3572 |
1.8200 |
2.3000 |
0.3400 |
0.5100 |
-74.50% |
| 2003 |
1.6622 |
1.5100 |
3.4500 |
0.8500 |
2.0000 |
24.22% |
| 2002 |
3.7409 |
7.0800 |
7.1800 |
1.0900 |
1.6100 |
-76.67% |
| 2001 |
7.3625 |
8.0000 |
9.7500 |
2.2500 |
6.9000 |
-6.44% |
| 2000 |
10.9355 |
11.8750 |
18.0625 |
4.5000 |
7.3750 |
-38.22% |
| 1999 |
8.0426 |
5.5000 |
11.9375 |
5.1250 |
11.9375 |
97.93% |
| 1998 |
13.2135 |
15.1250 |
20.2500 |
3.2500 |
6.0312 |
-58.41% |
| 1997 |
19.4099 |
21.2500 |
28.2500 |
11.7500 |
14.5000 |
-35.56% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED PRODUCTS |
$0.008B |
$0.000B |
|
GUIDED THERAPEUTICS, Inc. is developing a rapid and painless test for the early detection of disease that leads to cervical cancer. The technology is designed to quickly eliminate false positive Pap and HPV results and discover cervical disease missed by existing tests. Unlike Pap and HPV tests, the device does not require a painful tissue sample and results are available immediately. GT also owns technology for measuring substances in interstitial fluid, a secondary circulatory system in the body that surrounds the cells.
|
